sales@marketbusinessinsights.com | +1 (518)-300-1070
Market Business Insights Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
Request Sample Buy Now

Table Of Contents 

1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Glassia
        1.2.3 Aralast NP
        1.2.4 Prolastin C
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Specialty Clinics
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Perspective (2017-2028)
    2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Growth Trends by Region
        2.2.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Dynamics
        2.3.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Industry Trends
        2.3.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers
        2.3.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Challenges
        2.3.4 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue
        3.1.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue (2017-2022)
        3.1.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue
    3.4 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio
        3.4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2021
    3.5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players Head office and Area Served
    3.6 Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Solution and Service
    3.7 Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Type
    4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2023-2028)
5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Application
    5.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
    6.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
        6.2.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
        6.2.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
        6.2.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
    6.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
        6.3.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
        6.3.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
        6.3.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
    6.4 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
        6.4.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
        6.4.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
    7.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
        7.2.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
        7.2.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
        7.2.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
    7.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
        7.3.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
        7.3.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
        7.3.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
    7.4 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
        7.4.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
        7.4.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
        8.2.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
    8.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
        8.3.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
    8.4 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region
        8.4.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
    9.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
        9.2.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
        9.2.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
        9.2.3 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
    9.3 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
        9.3.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
        9.3.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
        9.3.3 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
    9.4 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
        9.4.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
        9.4.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
        10.2.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
    10.3 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
        10.3.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
    10.4 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
        10.4.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Grifols
        11.1.1 Grifols Company Details
        11.1.2 Grifols Business Overview
        11.1.3 Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
        11.1.4 Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
        11.1.5 Grifols Recent Developments
    11.2 CSL
        11.2.1 CSL Company Details
        11.2.2 CSL Business Overview
        11.2.3 CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
        11.2.4 CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
        11.2.5 CSL Recent Developments
    11.3 Baxter
        11.3.1 Baxter Company Details
        11.3.2 Baxter Business Overview
        11.3.3 Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
        11.3.4 Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
        11.3.5 Baxter Recent Developments
    11.4 Kamada
        11.4.1 Kamada Company Details
        11.4.2 Kamada Business Overview
        11.4.3 Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
        11.4.4 Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
        11.4.5 Kamada Recent Developments
    11.5 Takeda
        11.5.1 Takeda Company Details
        11.5.2 Takeda Business Overview
        11.5.3 Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
        11.5.4 Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
        11.5.5 Takeda Recent Developments
    11.6 Abeona
        11.6.1 Abeona Company Details
        11.6.2 Abeona Business Overview
        11.6.3 Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
        11.6.4 Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
        11.6.5 Abeona Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Glassia
    Table 3. Key Players of Aralast NP
    Table 4. Key Players of Prolastin C
    Table 5. Key Players of Others
    Table 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2017-2022)
    Table 10. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2023-2028)
    Table 12. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Trends
    Table 13. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers
    Table 14. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Challenges
    Table 15. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints
    Table 16. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Share by Players (2017-2022)
    Table 18. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2021)
    Table 19. Ranking of Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Solution and Service
    Table 23. Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2017-2022)
    Table 27. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2023-2028)
    Table 29. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Share by Application (2017-2022)
    Table 31. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Share by Application (2023-2028)
    Table 33. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Grifols Company Details
    Table 64. Grifols Business Overview
    Table 65. Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
    Table 66. Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
    Table 67. Grifols Recent Developments
    Table 68. CSL Company Details
    Table 69. CSL Business Overview
    Table 70. CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
    Table 71. CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
    Table 72. CSL Recent Developments
    Table 73. Baxter Company Details
    Table 74. Baxter Business Overview
    Table 75. Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
    Table 76. Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
    Table 77. Baxter Recent Developments
    Table 78. Kamada Company Details
    Table 79. Kamada Business Overview
    Table 80. Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
    Table 81. Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
    Table 82. Kamada Recent Developments
    Table 83. Takeda Company Details
    Table 84. Takeda Business Overview
    Table 85. Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
    Table 86. Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
    Table 87. Takeda Recent Developments
    Table 88. Abeona Company Details
    Table 89. Abeona Business Overview
    Table 90. Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
    Table 91. Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
    Table 92. Abeona Recent Developments
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type: 2021 VS 2028
    Figure 2. Glassia Features
    Figure 3. Aralast NP Features
    Figure 4. Prolastin C Features
    Figure 5. Others Features
    Figure 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application: 2021 VS 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Specialty Clinics Case Studies
    Figure 9. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Report Years Considered
    Figure 10. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region: 2021 VS 2028
    Figure 13. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Players in 2021
    Figure 14. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2021
    Figure 16. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
    Figure 18. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
    Figure 19. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Country (2017-2028)
    Figure 20. United States Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Country (2017-2028)
    Figure 26. Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Region (2017-2028)
    Figure 36. China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Country (2017-2028)
    Figure 46. Mexico Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Country (2017-2028)
    Figure 52. Turkey Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Grifols Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
    Figure 56. CSL Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
    Figure 57. Baxter Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
    Figure 58. Kamada Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
    Figure 59. Takeda Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
    Figure 60. Abeona Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
  1. Global Market, By Product Types, 2018-2028 (USD Million)
  2. Global Market, By Applications, 2018-2028 (USD Million)
  3. Global Secure Messaging, Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, By Region, 2018-2028 (USD Million)
  4. Global Web Portal, Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, By Region, 2018-2028 (USD Million)
  5. Global Private, Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, By Region, 2018-2028 (USD Million)
  6. Global Public,Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market, By Region, 2018-2028 (USD Million)
  7. North America Market, By Product Types, 2018-2028 (USD Million)
  8. North America Market, By Applications, 2018-2028 (USD Million)
  9. U.S. Market, By Product Types, 2018-2028 (USD Million)
  10. U.S. Market, By Applications, 2018-2028 (USD Million)
  11. Canada Market, By Product Types, 2018-2028 (USD Million)
  12. Canada Market, By Applications, 2018-2028 (USD Million)
  13. Mexico Market, By Product Types, 2018-2028 (USD Million)
  14. Mexico Market, By Applications, 2018-2028 (USD Million)
  15. Europe Market, By Product Types, 2018-2028 (USD Million)
  16. Europe Market, By Applications, 2018-2028 (USD Million)
  17. U.K. Market, By Product Types, 2018-2028 (USD Million)
  18. U.K. Market, By Applications, 2018-2028 (USD Million)
  19. Germany Market, By Product Types, 2018-2028 (USD Million)
  20. Germany Market, By Applications, 2018-2028 (USD Million)
  21. Italy Market, By Product Types, 2018-2028 (USD Million)
  22. Italy Market, By Applications, 2018-2028 (USD Million)
  23. France Market, By Product Types, 2018-2028 (USD Million)
  24. France Market, By Applications, 2018-2028 (USD Million)
  25. Russia Market, By Product Types, 2018-2028 (USD Million)
  26. Russia Market, By Applications, 2018-2028 (USD Million)
  27. Asia-Pacific Market, By Product Types, 2018-2028 (USD Million)
  28. Asia-Pacific Market, By Applications, 2018-2028 (USD Million)
  29. India Market, By Product Types, 2018-2028 (USD Million)
  30. India Market, By Applications, 2018-2028 (USD Million)
  31. Japan Market, By Product Types, 2018-2028 (USD Million)
  32. Japan Market, By Applications, 2018-2028 (USD Million)
  33. China Market, By Product Types, 2018-2028 (USD Million)
  34. China Market, By Applications, 2018-2028 (USD Million)
  35. South Korea Market, By Product Types, 2018-2028 (USD Million)
  36. South Korea Market, By Applications, 2018-2028 (USD Million)
  37. Australia Market, By Product Types, 2018-2028 (USD Million)
  38. Australia Market, By Applications, 2018-2028 (USD Million)
  39. Latin America Market, By Product Types, 2018-2028 (USD Million)
  40. Latin America Market, By Applications, 2018-2028 (USD Million)
  41. Brazil Market, By Product Types, 2018-2028 (USD Million)
  42. Brazil Market, By Applications, 2018-2028 (USD Million)
  43. Middle East & Africa Market, By Product Types, 2018-2028 (USD Million)
  44. Middle East & Africa Market, By Applications, 2018-2028 (USD Million)
  45. Saudi Arabia Market, By Product Types, 2018-2028 (USD Million)
  46. Saudi Arabia Market, By Applications, 2018-2028 (USD Million)
  47. UAE Market, By Product Types, 2018-2028 (USD Million)
  48. UAE Market, By Applications, 2018-2028 (USD Million)
  49. South Africa Market, By Product Types, 2018-2028 (USD Million)
  50. South Africa Market, By Applications, 2018-2028 (USD Million)
  1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Segmentation
  2. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-Down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Global Market Attractiveness Analysis By Product Types
  9. Global Market Attractiveness Analysis By Applications
  10. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Attractiveness Analysis ByRegion
  11. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market: Dynamics
  12. Global Market Share By Product Types (2021 & 2028)
  13. Global Market Share By Applications (2021 & 2028)
  14. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share By Region (2021 & 2028)
  15. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share By Company (2020)
We Accept
Select License
Includes
  • Purchase Report Sections
  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Latest Reports